Chronic Pain Linked to Treatment-Resistant Depression in Brazil
A study published in the journal Nature Mental Health on 28 April argues that many patients classified with treatment‑resistant depression may actually be experiencing unmeasured chronic pain, which can diminish antidepressant response. The researchers note that current definitions of treatment‑resistant depression do not require assessment of pain, and that widely used rating scales such as the PHQ‑9 and Hamilton Depression Rating Scale do not directly evaluate pain burden.
One of the authors, Nilson Mendes Neto of Harvard Medical School, explains that there is a crucial difference between a doctor simply knowing a patient feels pain and having a structured measurement of that pain incorporated into the evaluation. He says, “Today, the classification of treatment‑resistant depression is based mainly on failure of adequately dosed antidepressant trials; the presence, intensity and functional impact of pain are not part of the formal definition.” The authors recommend systematic pain screening in Brazil’s public health system (SUS) and stress that patients should not alter or stop their medication based on these findings alone.
Entities: Brazil · Harvard Medical School · Nature Mental Health · Nilson Mendes Neto · Sistema Único de Saúde (SUS)
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 4 SOURCES] The authors recommend systematic pain screening in Brazil’s public health system (SUS). (Study authors)
- [● 4 SOURCES] Patients should not change or stop their antidepressant medication based solely on the article’s findings. (Study authors)
- [● 4 SOURCES] A study published in Nature Mental Health on 28 April argues that unmeasured chronic pain may explain many cases classified as treatment‑resistant depression. (Nature Mental Health article)
- [● 4 SOURCES] Current definitions of treatment‑resistant depression do not require assessment of chronic pain. (Study authors)
- [● 4 SOURCES] Chronic pain is common among people with depression and reduces their response to antidepressants. (Study authors)
- [● 4 SOURCES] Common depression rating scales such as PHQ‑9 and the Hamilton scale do not directly evaluate pain. (Study authors)
- [● 4 SOURCES] Nilson Mendes Neto of Harvard Medical School says lack of structured pain measurement can influence treatment outcomes for depression. (Nilson Mendes Neto)
- [● 4 SOURCES] The study calls for integrating pain measurement into depression assessment frameworks. (Study authors)